Advertisement

Reactions Weekly

, Volume 1709, Issue 1, pp 252–252 | Cite as

Tolvaptan

Aggravation of kidney function: case report
Case report
  • 21 Downloads

Reference

  1. Kai H, et al. A prospective study of the efficacy and adverse effectsof tolvaptan for autosomal dominant polycystic kidney disease (ADPKD). Nephrology Dialysis Transplantation 33 (Suppl. 1): i68, May 2018. Available from: URL: http://doi.org/10.1093/ndt/gfy104.FP061 [abstract] - Japan

Copyright information

© Springer Nature Switzerland AG 2018

Personalised recommendations